Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo	0	48
Total, all-cause mortality	PF-06650833 400mg QD	0	47
Total, all-cause mortality	PF-06700841 45mg QD	0	52
Total, all-cause mortality	PF-06826647 400mg QD	0	47
Total, other adverse events	Placebo	6	48
Total, other adverse events	PF-06650833 400mg QD	10	47
Total, other adverse events	PF-06700841 45mg QD	14	52
Total, other adverse events	PF-06826647 400mg QD	18	47
Total, serious adverse events	Placebo	0	48
Total, serious adverse events	PF-06650833 400mg QD	2	47
Total, serious adverse events	PF-06700841 45mg QD	0	52
Total, serious adverse events	PF-06826647 400mg QD	2	47

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04092452/event-totals